Clear Point Advisors Inc. cut its stake in iShares MSCI India ETF (BATS:INDA – Free Report) by 1.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,028 shares of the company’s stock after selling 240 shares during the quarter. Clear Point Advisors Inc.’s holdings in iShares MSCI India ETF were worth $838,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Angeles Wealth Management LLC purchased a new stake in iShares MSCI India ETF in the 2nd quarter valued at $25,000. Founders Capital Management purchased a new stake in shares of iShares MSCI India ETF in the second quarter valued at about $28,000. Abound Wealth Management bought a new position in shares of iShares MSCI India ETF during the second quarter valued at about $28,000. Principal Securities Inc. purchased a new position in iShares MSCI India ETF during the fourth quarter worth about $29,000. Finally, Bogart Wealth LLC purchased a new position in iShares MSCI India ETF during the first quarter worth about $33,000.
iShares MSCI India ETF Stock Performance
BATS:INDA opened at $58.89 on Wednesday. iShares MSCI India ETF has a 52 week low of $30.57 and a 52 week high of $38.21. The firm has a 50-day moving average price of $56.85 and a two-hundred day moving average price of $54.46. The firm has a market cap of $10.88 billion, a price-to-earnings ratio of 28.95 and a beta of 0.51.
iShares MSCI India ETF Company Profile
The iShares MSCI India ETF (INDA) is an exchange-traded fund that is based on the MSCI India index, a market-cap-weighted index of the top 85% of firms in the Indian securities market. INDA was launched on Feb 2, 2012 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares MSCI India ETF
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Stock Sentiment Analysis: How it Works
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is the S&P/TSX Index?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding INDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares MSCI India ETF (BATS:INDA – Free Report).
Receive News & Ratings for iShares MSCI India ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares MSCI India ETF and related companies with MarketBeat.com's FREE daily email newsletter.